Product Information
LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB is a generic product labeled by Jubilant Cadista Pharmaceuticals Inc., priced at $0.0872 per EA under NDC 59746033990. Its NADAC has been published 619 times since Nov 28, 2013.
FDA first approved this application on Sep 18, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the losartan potassium and hydrochlorothiazide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
25; 100 mg/1; mg/1
Manufacturer
Jubilant Cadista Pharmaceuticals Inc.NDC
59746033990
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/17/2025
Active Ingredients
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUMApproval Type
Generic (ANDA)
FDA Application
ANDA201845FDA Approved
9/18/2012
TE Code
AB
On Market Since
10/30/2012
Pharmacological Classes
Price Statistics
The NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB has been published 619 times since Nov 28, 2013, and over the history we have for it it has declined 27.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0872 per EA |
|---|---|
| All-time high | $0.2811 (May 11, 2022) |
| All-time low | $0.0771 (Jan 23, 2019) |
| 52-week high | $0.0872 |
| 52-week low | $0.0848 |
| Median price | $0.1140 |
| Average price | $0.1241 |
| Largest weekly change | +41.4% (Jan 29, 2020) |
| Weeks tracked | 619 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
+2.8%
3Y
-30.1%
5Y
-49.4%
All
-27.7%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 10% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB, manufactured by Jubilant Cadista Pharmaceuticals Inc., is $0.0872 per EA (NDC 59746033990), effective Oct 1, 2025.
How has the price of LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB changed over time?
Over the history we have for it, the NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB has declined 27.7%. It has been tracked across 619 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB?
Since Nov 28, 2013, the NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB has ranged from a low of $0.0771 (Jan 23, 2019) to a high of $0.2811 (May 11, 2022), with a median of $0.1140 per EA.
Are there cheaper alternatives to LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB, is $0.0783 per EA — about 10% below LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB.
Who manufactures LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB?
LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB (NDC 59746033990) is labeled by Jubilant Cadista Pharmaceuticals Inc., and CMS classifies it as a generic product.